Fluctuations in plasma macrophage colony-stimulating factor levels during autologous peripheral blood stem cell transplantation for haematologic diseases

被引:2
作者
Saigo, K
Sugimoto, T
Matsui, T
Ryo, R
Kumagai, S
机构
[1] Kobe Univ Hosp, Div Blood Transfus, Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Kyodo Hosp, Sect Internal Med, Kobe, Hyogo, Japan
[3] Kobe Univ, Sch Med, Dept Haematol, Kobe, Hyogo 650, Japan
[4] Kobe Univ, Sch Med, Fac Hlth Sci, Kobe, Hyogo 650, Japan
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2002年 / 24卷 / 01期
关键词
M-CSF; peripheral blood stem cell transplantation; endothelial cells; thrombomodulin;
D O I
10.1046/j.1365-2257.2002.00156.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma macrophage colony-stimulating factor (M-CSF) levels were measured in 13 haematologic patients treated with autologous peripheral blood stem cell transplantation (PBSCT). Six of the patients showed an increase in M-CSF peak levels (> 3000 pg/ml) during the conditioning and stem cell infusion period. The peak levels of M-CSF in this phase correlated with thrombomodulin levels, indicating the endothelial origin of plasma M-CSF. However, the M-CSF levels were not influenced by TNFalpha. More patients with high M-CSF levels (> 5000 pg/ml) suffered from organ failure than those with lower M-CSF levels. These results suggest that high M-CSF levels may correlate with cellular or organ damage in patients treated with PBSCT.
引用
收藏
页码:37 / 42
页数:6
相关论文
共 19 条
[1]   Effect of cytokines and growth factors on the macrophage colony-stimulating factor secretion by human bone marrow stromal cells [J].
Besse, A ;
Trimoreau, F ;
Praloran, V ;
Denizot, Y .
CYTOKINE, 2000, 12 (05) :522-+
[2]  
BLAISE D, 1992, BLOOD, V79, P2578
[3]  
CHOU T, 1999, JPN J CLIN HEMATOL, V40, P1058
[4]   MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE [J].
FIELDS, KK ;
ELFENBEIN, GJ ;
LAZARUS, HM ;
COOPER, BW ;
PERKINS, JB ;
CREGER, RJ ;
BALLESTER, OF ;
HIEMENZ, JH ;
JANSSEN, WE ;
ZORSKY, PE .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :323-332
[5]   A comparison of macrophage colony-stimulating factor (M-CSF) gene expression in primary and immortalized endothelial cells [J].
Green, M ;
Harrington, MA .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (02) :237-246
[6]   Macrophage colony-stimulating factor (M-CSF) augments cytokine induction by lipopolysaccharide (LPS)-stimulation and by bacterial infections in mice [J].
Hanamura, T ;
Asakura, E ;
Tanabe, T .
IMMUNOPHARMACOLOGY, 1997, 37 (01) :15-23
[7]   Activation of mesangial cells with TNF-alpha stimulates M-CSF gene expression and monocyte proliferation: Evidence for involvement of protein kinase C and protein tyrosine kinase [J].
Kamanna, VS ;
Pai, R ;
Bassa, B ;
Kirschenbaum, MA .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1996, 1313 (02) :161-172
[8]  
KIMURA F, 1992, INT J HEMATOL, V55, P147
[9]  
Logan TF, 1996, EXP HEMATOL, V24, P49
[10]   DOUBLE-BLIND TEST OF HUMAN URINARY MACROPHAGE COLONY-STIMULATING FACTOR FOR ALLOGENEIC AND SYNGENEIC BONE-MARROW TRANSPLANTATION - EFFECTIVENESS OF TREATMENT AND 2-YEAR FOLLOW-UP FOR RELAPSE OF LEUKEMIA [J].
MASAOKA, T ;
SHIBATA, H ;
OHNO, R ;
KATOH, S ;
HARADA, M ;
MOTOYOSHI, K ;
TAKAKU, F ;
SAKUMA, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 76 (04) :501-505